Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley C Jordan

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|February 19, 2019
Immune response to non-HLA antigens and renal allograft lossStanley C Jordan
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2002
Management of the highly HLA- sensitized patient. A novel role for intravenous gammaglobulinStanley C Jordan
Transplantation|February 12, 2021
Obinutuzumab for Desensitization: An Unexpected Benefit?Stanley C Jordan
Expert Review of Clinical Immunology|October 20, 2012
Advancing kidney transplantationStanley C Jordan
Transplantation|September 16, 2024
Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal AllograftsStanley C Jordan
Pediatric Transplantation|January 18, 2012
Complement fixing donor-specific antibodies and allograft lossStanley C Jordan
Kidney International Reports|November 24, 2025
Clazakizumab: A Therapeutic Approach for Patients With Late Antibody-Mediated RejectionStanley C Jordan
Journal of the American Society of Nephrology : JASN|August 22, 2015
Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft RecipientsStanley C Jordan
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 1, 2025
Continued optimism for the use of imlifidase for desensitization in kidney transplantStanley C Jordan
Nature Reviews. Nephrology|August 25, 2009
Transplantation: ABO-incompatible renal transplants: time for increased use?Stanley C Jordan
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|February 19, 2019
Immune response to non-HLA antigens and renal allograft lossStanley C Jordan
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2002
Management of the highly HLA- sensitized patient. A novel role for intravenous gammaglobulinStanley C Jordan
Transplantation|February 12, 2021
Obinutuzumab for Desensitization: An Unexpected Benefit?Stanley C Jordan
Expert Review of Clinical Immunology|October 20, 2012
Advancing kidney transplantationStanley C Jordan
Transplantation|September 16, 2024
Anti-CD38 Monoclonals for Treatment of Antibody-mediated Rejection in Renal AllograftsStanley C Jordan
Pediatric Transplantation|January 18, 2012
Complement fixing donor-specific antibodies and allograft lossStanley C Jordan
Kidney International Reports|November 24, 2025
Clazakizumab: A Therapeutic Approach for Patients With Late Antibody-Mediated RejectionStanley C Jordan
Journal of the American Society of Nephrology : JASN|August 22, 2015
Donor-Specific HLA Antibody IgG Subclasses Are Associated with Phenotypes of Antibody-Mediated Rejection in Sensitized Renal Allograft RecipientsStanley C Jordan
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 1, 2025
Continued optimism for the use of imlifidase for desensitization in kidney transplantStanley C Jordan
Nature Reviews. Nephrology|August 25, 2009
Transplantation: ABO-incompatible renal transplants: time for increased use?Stanley C Jordan
Pageof 20